Scientists have developed a vaccine that protects mice against a deadly form of the Ebola virus.
First identified in 1976, Ebola fever kills more than 90% of the people it infects.
The researchers say that this is the first Ebola vaccine to remain viable long-term and can therefore be successfully stockpiled.
The results are reported in the journal Proceedings of National Academy of Sciences.
Ebola is transmitted via bodily fluids, and can become airborne. Sufferers experience nausea, vomiting, internal bleeding and organ failure before they die.
Although few people contract Ebola each year, its effects are so swift and devastating that it is often feared that it could be used against humans in an act of terrorism.
Custom Medical Stock Photo represents over 100,000 medical and scientific images available for use by purchasing a copyright license.
Email our sales desk at photos@cmsp.com
Posts
0 comments:
Post a Comment